tradingkey.logo
tradingkey.logo
Search

Novo Nordisk A/S

NVO
Add to Watchlist
44.010USD
-0.550-1.23%
Close 09-09 16:00ET
147.54BMarket Cap
10.30P/E TTM

NVO Income Statement

You can find the annual or quarterly income statement of Novo Nordisk A/S here for insights into the performance and operational efficiency of Novo Nordisk A/S.
Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
4.55%12.21B
37.80%15.17B
0.69%12.34B
11.81%11.74B
18.85%11.67B
15.63%11.01B
28.92%12.25B
22.51%10.50B
23.78%9.82B
23.77%9.52B
44.11%9.50B
38.88%8.57B
34.20%7.94B
21.33%7.69B
11.89%6.60B
9.31%6.17B
10.52%5.91B
15.66%6.34B
14.50%5.89B
16.39%5.65B
20.79%5.35B
9.58%5.48B
7.17%5.15B
7.58%4.85B
-2.02%4.43B
12.22%5.00B
5.67%4.80B
4.19%4.51B
3.04%4.52B
0.37%4.46B
2.61%4.55B
2.99%4.33B
3.67%4.39B
8.95%4.44B
3.34%4.43B
1.82%4.20B
1.51%4.23B
1.28%4.08B
1.17%4.29B
3.37%4.13B
3.94%4.17B
5.49%4.02B
2.78%4.24B
0.96%3.99B
0.87%4.01B
2.08%3.81B
4.12%4.12B
8.53%3.96B
6.18%3.98B
5.66%3.74B
8.61%3.96B
9.27%3.65B
11.33%3.74B
12.99%3.54B
--3.65B
--3.34B
--3.36B
--3.13B
Revenue
4.55%12.21B
37.80%15.17B
0.69%12.34B
11.81%11.74B
18.85%11.67B
15.63%11.01B
28.92%12.25B
22.51%10.50B
23.78%9.82B
23.77%9.52B
44.11%9.50B
38.88%8.57B
34.20%7.94B
21.33%7.69B
11.89%6.60B
9.31%6.17B
10.52%5.91B
15.66%6.34B
14.50%5.89B
16.39%5.65B
20.79%5.35B
9.58%5.48B
7.17%5.15B
7.58%4.85B
-2.02%4.43B
12.22%5.00B
5.67%4.80B
4.19%4.51B
3.04%4.52B
0.37%4.46B
2.61%4.55B
2.99%4.33B
3.67%4.39B
8.95%4.44B
3.34%4.43B
1.82%4.20B
1.51%4.23B
1.28%4.08B
1.17%4.29B
3.37%4.13B
3.94%4.17B
5.49%4.02B
2.78%4.24B
0.96%3.99B
0.87%4.01B
2.08%3.81B
4.12%4.12B
8.53%3.96B
6.18%3.98B
5.66%3.74B
8.61%3.96B
9.27%3.65B
11.33%3.74B
12.99%3.54B
--3.65B
--3.34B
--3.36B
--3.13B
Cost of revenue
36.29%2.66B
17.24%2.13B
26.79%2.36B
68.37%2.80B
31.60%1.95B
25.79%1.82B
28.89%1.86B
17.47%1.67B
29.15%1.48B
22.50%1.44B
27.54%1.45B
45.35%1.42B
32.01%1.15B
13.04%1.18B
18.06%1.13B
1.54%975.49M
-3.18%869.63M
10.72%1.04B
6.62%959.73M
18.77%960.66M
27.51%898.16M
18.48%942.19M
11.82%900.15M
6.98%808.86M
-3.48%704.38M
10.44%795.25M
13.15%805.00M
9.81%756.06M
4.76%729.75M
4.05%720.05M
-4.36%711.48M
2.03%688.49M
6.93%696.57M
13.65%692.05M
4.33%743.93M
12.91%674.78M
6.09%651.44M
-2.74%608.94M
5.43%713.04M
4.20%597.61M
7.36%614.02M
6.77%626.13M
0.83%676.31M
-5.85%573.50M
-15.24%571.92M
-7.90%586.43M
8.08%670.74M
-2.76%609.16M
6.85%674.78M
-0.32%636.71M
13.15%620.60M
6.94%626.44M
6.76%631.54M
6.44%638.75M
--548.50M
--585.81M
--591.56M
--600.08M
Operating expenses
7.06%6.96B
5.23%5.83B
4.15%7.29B
18.57%6.55B
23.59%6.50B
13.49%5.54B
24.06%7.00B
18.88%5.52B
18.28%5.26B
19.41%4.88B
32.69%5.64B
35.07%4.64B
35.59%4.44B
18.43%4.09B
11.95%4.25B
6.46%3.44B
10.84%3.28B
13.09%3.45B
13.12%3.80B
13.62%3.23B
23.90%2.96B
17.62%3.05B
10.29%3.36B
9.94%2.84B
-4.38%2.39B
13.28%2.59B
5.08%3.04B
3.97%2.59B
2.57%2.50B
-4.89%2.29B
2.01%2.90B
8.07%2.49B
7.98%2.43B
12.36%2.41B
6.67%2.84B
1.54%2.30B
-0.78%2.25B
-2.75%2.14B
-0.31%2.66B
2.64%2.27B
5.13%2.27B
6.12%2.20B
3.23%2.67B
-9.22%2.21B
-8.86%2.16B
-8.17%2.08B
-1.17%2.59B
9.33%2.43B
5.78%2.37B
2.87%2.26B
12.40%2.62B
10.47%2.22B
9.78%2.24B
9.68%2.20B
--2.33B
--2.01B
--2.04B
--2.00B
R&D expenses
55.78%2.77B
10.88%1.61B
15.69%2.28B
72.52%2.41B
17.56%1.78B
15.90%1.45B
30.76%1.97B
17.78%1.40B
45.02%1.51B
29.29%1.25B
36.14%1.51B
55.47%1.19B
41.88%1.04B
23.50%969.67M
28.02%1.11B
13.21%763.18M
14.95%734.08M
22.78%785.17M
20.60%866.08M
9.86%674.16M
31.46%638.61M
14.67%639.47M
10.54%718.17M
14.39%613.67M
-9.25%485.78M
36.85%557.68M
-6.49%649.69M
-5.59%536.47M
1.47%535.31M
-25.59%407.50M
10.21%694.81M
8.10%568.26M
4.58%527.55M
16.23%547.61M
-2.72%630.44M
1.39%525.67M
-0.24%504.43M
-3.57%471.14M
9.46%648.08M
5.74%518.44M
12.41%505.64M
-0.69%488.60M
-8.67%592.07M
-24.53%490.32M
-20.42%449.80M
-15.46%491.97M
-0.40%648.27M
30.80%649.70M
18.87%565.23M
23.75%581.97M
16.56%650.90M
12.91%496.71M
7.38%475.50M
6.37%470.26M
--558.41M
--439.90M
--442.81M
--442.08M
Depreciation, depletion, and amortization
-12.08%560.58M
2.66%553.97M
49.99%1.11B
214.27%995.25M
40.49%637.61M
27.11%539.61M
493.46%743.38M
-14.09%316.68M
42.66%453.86M
71.34%424.50M
-25.50%125.26M
33.30%368.60M
35.71%318.13M
-0.44%247.75M
-20.08%168.14M
29.29%276.52M
18.96%234.42M
11.46%248.85M
-4.77%210.37M
-36.00%213.88M
15.28%197.06M
39.24%223.26M
6.63%220.91M
7.08%334.21M
2.32%170.93M
-0.40%160.35M
-17.48%207.18M
155.61%312.11M
35.90%167.05M
33.38%160.99M
75.27%251.07M
9.49%122.10M
-3.60%122.92M
19.01%120.70M
-11.47%143.25M
1.06%111.52M
17.16%127.51M
9.91%101.42M
8.61%161.80M
16.93%110.35M
13.33%108.84M
-8.06%92.28M
-4.29%148.97M
-55.14%94.37M
-21.67%96.04M
-16.84%100.36M
8.08%155.65M
84.08%210.34M
488.27%122.60M
-1.31%120.69M
9.65%144.02M
5.56%114.27M
-81.61%20.84M
8.71%122.30M
--131.34M
--108.25M
--113.34M
--112.50M
Other operating expenses
-981.53%-1.01B
836.29%16.61M
-127.86%-73.27M
-9971.81%-1.47B
-59.04%-92.95M
-102.73%-2.26M
60848.27%263.00M
203.99%14.88M
-2766.33%-58.45M
1839.75%82.74M
99.27%-432.93K
-75.99%-14.31M
110.27%2.19M
91.96%-4.76M
-9753.87%-59.38M
36.70%-8.13M
1.60%-21.35M
-201.35%-59.12M
103.62%615.12K
35.55%-12.84M
-22.49%-21.70M
-24.18%-19.62M
-166.47%-16.98M
-52.00%-19.93M
53.66%-17.71M
51.71%-15.80M
82.99%-6.37M
50.55%-13.11M
38.13%-38.23M
13.36%-32.72M
-56.74%-37.46M
60.32%-26.51M
-121.24%-61.78M
5.18%-37.76M
-69.95%-23.90M
-120.62%-66.81M
-19.46%-27.93M
5.18%-39.82M
-126.99%-14.06M
10.51%-30.29M
58.38%-23.38M
31.66%-42.00M
270.68%52.10M
-12.62%-33.84M
-49.79%-56.17M
-55.61%-61.46M
6.57%-30.53M
-11.24%-30.05M
-22.35%-37.50M
-26.79%-39.50M
-20.40%-32.67M
13.60%-27.01M
-15.19%-30.65M
-3.91%-31.15M
---27.14M
---31.27M
---26.61M
---29.98M
Operating profit
1.41%5.25B
70.80%9.34B
-3.92%5.05B
4.31%5.20B
13.40%5.18B
17.87%5.47B
36.02%5.25B
26.80%4.98B
30.77%4.57B
28.72%4.64B
64.83%3.86B
43.67%3.93B
32.47%3.49B
24.81%3.60B
11.77%2.34B
13.11%2.73B
10.12%2.64B
18.88%2.89B
17.08%2.10B
20.30%2.42B
17.15%2.39B
0.92%2.43B
1.77%1.79B
4.42%2.01B
0.90%2.04B
11.09%2.41B
6.72%1.76B
4.48%1.92B
3.64%2.02B
6.60%2.17B
3.68%1.65B
-3.17%1.84B
-1.24%1.95B
5.18%2.03B
-2.12%1.59B
2.17%1.90B
4.26%1.98B
6.16%1.93B
3.69%1.62B
4.26%1.86B
2.55%1.90B
4.74%1.82B
2.02%1.57B
17.22%1.79B
15.24%1.85B
17.77%1.74B
14.42%1.54B
7.28%1.52B
6.76%1.61B
10.26%1.48B
1.91%1.34B
7.44%1.42B
13.72%1.50B
18.87%1.34B
--1.32B
--1.32B
--1.32B
--1.13B
Net non-operating interest income (expenses)
Non-operating interest income
-74.68%204.33M
96.41%948.29M
-82.89%95.72M
-76.39%48.09M
482.59%807.11M
54.43%482.80M
115.67%559.61M
-57.94%203.71M
46.53%138.54M
154.59%312.62M
--259.47M
127.28%484.36M
-60.15%94.55M
287.70%122.79M
----
70.15%213.12M
1528.32%237.29M
-88.86%31.67M
-81.97%39.06M
392.76%125.25M
1.78%14.57M
11223.56%284.23M
7207.44%216.59M
903.67%25.42M
534.26%14.32M
26.89%2.51M
--2.96M
--2.53M
-98.64%2.26M
-99.00%1.98M
----
----
167.35%166.30M
434.51%197.54M
--27.70M
--61.92M
290.27%62.20M
986.59%36.96M
----
----
--15.94M
-92.12%3.40M
--2.64M
-97.69%1.34M
----
-59.92%43.14M
----
-21.97%57.96M
14.50%72.79M
93.09%107.65M
3640.31%110.61M
--74.28M
152.04%63.57M
572.68%55.75M
--2.96M
----
--25.22M
--8.29M
Non-operating interest expense
-69.03%233.25M
-24.97%548.17M
----
----
234.07%753.04M
141.82%730.61M
434.66%728.36M
----
448.94%225.41M
86.84%302.14M
--136.23M
-37.29%316.49M
-91.19%41.06M
-25.44%161.71M
----
243.37%504.68M
--465.98M
67.83%216.88M
40.90%119.18M
235.74%146.98M
----
-32.57%129.22M
-29.88%84.58M
-64.55%43.78M
-61.49%76.61M
22.28%191.65M
109.82%120.63M
32.66%123.50M
66.85%198.95M
2468.94%156.73M
--57.49M
--93.10M
-30.67%119.24M
-94.28%6.10M
----
----
--171.98M
90.15%106.58M
-71.04%35.23M
-93.70%17.39M
----
-77.66%56.05M
--121.67M
252.29%276.24M
883.09%252.99M
329.38%250.83M
----
297.50%78.41M
-44.97%25.73M
205.61%58.42M
30.20%31.03M
-72.06%19.73M
-68.38%46.76M
-71.09%19.11M
--23.83M
--70.60M
--147.89M
--66.13M
Gains from sale of securities
----
----
--286.07M
297.92%239.34M
----
----
----
---120.93M
----
----
----
----
----
----
---105.74M
----
----
----
----
----
--7.77M
----
----
----
----
----
----
----
----
----
-110.24%-5.66M
-396.18%-12.16M
----
----
1914.33%55.24M
1013.07%4.11M
----
----
---3.04M
---449.78K
----
----
----
----
---33.64M
----
---135.02M
----
----
----
----
----
----
----
----
---14.29M
----
----
Special income (expenses)
-980.09%-1.04B
100.00%0.00
---100.40M
---1.49B
88.28%-96.45M
---281.93K
----
----
---822.58M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
--20.12M
--0.00
----
----
----
----
--0.00
--0.00
-100.00%0.00
--65.90M
--0.00
--0.00
--359.67M
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-18.61%4.18B
86.58%9.74B
4.80%5.33B
-21.08%4.00B
40.45%5.13B
12.27%5.22B
27.58%5.09B
23.63%5.06B
3.14%3.66B
30.42%4.65B
78.13%3.99B
67.69%4.10B
47.28%3.54B
31.92%3.57B
10.96%2.24B
1.96%2.44B
-0.36%2.41B
4.58%2.70B
4.88%2.02B
20.32%2.40B
21.97%2.42B
16.52%2.58B
17.10%1.92B
10.40%1.99B
8.35%1.98B
10.24%2.22B
3.55%1.64B
3.84%1.80B
-8.63%1.83B
-10.34%2.01B
-5.23%1.59B
-11.76%1.74B
7.09%2.00B
20.47%2.24B
5.47%1.67B
6.73%1.97B
-2.35%1.87B
5.38%1.86B
4.80%1.59B
22.05%1.84B
22.37%1.91B
-6.47%1.77B
8.06%1.51B
0.52%1.51B
-5.39%1.56B
23.94%1.89B
-1.48%1.40B
1.92%1.50B
8.68%1.65B
10.90%1.52B
9.69%1.42B
19.23%1.47B
26.75%1.52B
28.74%1.38B
--1.30B
--1.24B
--1.20B
--1.07B
Income tax
-17.47%915.28M
89.17%2.13B
8.52%1.14B
-17.26%863.21M
45.50%1.11B
18.88%1.13B
28.36%1.05B
27.96%1.04B
8.08%762.25M
33.68%948.51M
118.53%816.37M
65.91%815.30M
41.55%705.24M
26.84%709.53M
9.38%373.57M
3.55%491.40M
10.13%498.22M
4.08%559.39M
-20.57%341.54M
26.38%474.54M
9.81%452.40M
16.53%537.49M
22.83%429.97M
31.75%375.48M
7.35%411.97M
9.16%461.26M
22.22%350.04M
-13.02%284.99M
11.26%383.76M
-10.33%422.57M
-21.94%286.40M
-22.95%327.64M
-13.28%344.93M
15.52%471.26M
12.82%366.90M
13.54%425.21M
-0.52%397.75M
10.44%407.96M
7.77%325.20M
43.31%374.52M
22.35%399.83M
-6.47%369.40M
-1.31%301.76M
-24.78%261.33M
-10.88%326.79M
16.65%394.94M
-3.56%305.77M
3.77%347.43M
7.54%366.71M
7.05%338.56M
7.40%317.05M
17.72%334.81M
23.59%340.99M
28.76%316.28M
--295.21M
--284.42M
--275.91M
--245.64M
Income after tax
-18.92%3.26B
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
16.51%2.05B
15.55%1.49B
6.40%1.62B
8.61%1.57B
10.52%1.76B
-0.57%1.29B
7.76%1.52B
-12.77%1.44B
-10.34%1.59B
-0.54%1.30B
-8.68%1.41B
12.60%1.66B
21.85%1.77B
3.57%1.31B
5.00%1.54B
-2.83%1.47B
4.05%1.45B
4.06%1.26B
17.60%1.47B
22.37%1.51B
-6.47%1.40B
10.68%1.21B
8.13%1.25B
-3.82%1.24B
26.02%1.49B
-0.88%1.10B
1.38%1.16B
9.01%1.29B
12.05%1.19B
10.36%1.10B
19.68%1.14B
27.69%1.18B
28.73%1.06B
--1.00B
--952.59M
--923.63M
--822.45M
Net income from continuous operations
-18.92%3.26B
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
16.51%2.05B
15.55%1.49B
6.40%1.62B
8.61%1.57B
10.52%1.76B
-0.57%1.29B
7.76%1.52B
-12.77%1.44B
-10.34%1.59B
-0.54%1.30B
-8.68%1.41B
12.60%1.66B
21.85%1.77B
3.57%1.31B
5.00%1.54B
-2.83%1.47B
4.05%1.45B
4.06%1.26B
17.60%1.47B
22.37%1.51B
-6.47%1.40B
10.68%1.21B
8.13%1.25B
-3.82%1.24B
26.02%1.49B
-0.88%1.10B
1.38%1.16B
9.01%1.29B
12.05%1.19B
10.36%1.10B
19.68%1.14B
27.69%1.18B
28.73%1.06B
--1.00B
--952.59M
--923.63M
--822.45M
Net income attributable to controlling interests
-18.92%3.26B
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
16.51%2.05B
15.55%1.49B
6.40%1.62B
8.61%1.57B
10.52%1.76B
-0.57%1.29B
7.76%1.52B
-12.77%1.44B
-10.34%1.59B
-0.54%1.30B
-8.68%1.41B
12.60%1.66B
21.85%1.77B
3.57%1.31B
5.00%1.54B
-2.83%1.47B
4.05%1.45B
4.06%1.26B
17.60%1.47B
22.37%1.51B
-6.47%1.40B
10.68%1.21B
8.13%1.25B
-3.82%1.24B
26.02%1.49B
-0.88%1.10B
1.38%1.16B
9.01%1.29B
12.05%1.19B
10.36%1.10B
19.68%1.14B
27.69%1.18B
28.73%1.06B
--1.00B
--952.59M
--923.63M
--822.45M
Net income attributable to common shareholders
-18.92%3.26B
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
16.51%2.05B
15.55%1.49B
6.40%1.62B
8.61%1.57B
10.52%1.76B
-0.57%1.29B
7.76%1.52B
-12.77%1.44B
-10.34%1.59B
-0.54%1.30B
-8.68%1.41B
12.60%1.66B
21.85%1.77B
3.57%1.31B
5.00%1.54B
-2.83%1.47B
4.05%1.45B
4.06%1.26B
17.60%1.47B
22.37%1.51B
-6.47%1.40B
10.68%1.21B
8.13%1.25B
-3.82%1.24B
26.02%1.49B
-0.88%1.10B
1.38%1.16B
9.01%1.29B
12.05%1.19B
10.36%1.10B
19.68%1.14B
27.69%1.18B
28.73%1.06B
--1.00B
--952.59M
--923.63M
--822.45M
Basic earnings per share
-18.78%0.74
85.74%1.71
4.03%0.94
-21.92%0.71
39.57%0.91
11.02%0.92
26.73%0.91
23.23%0.90
2.66%0.65
30.83%0.83
74.89%0.72
69.87%0.73
50.36%0.63
34.83%0.63
12.96%0.41
2.93%0.43
-1.43%0.42
6.24%0.47
11.72%0.36
20.84%0.42
27.23%0.43
18.49%0.44
18.30%0.32
8.22%0.35
10.53%0.34
12.47%0.37
1.33%0.27
9.83%0.32
-11.10%0.30
-8.58%0.33
1.45%0.27
-6.73%0.29
15.12%0.34
24.78%0.36
6.29%0.27
7.59%0.31
-0.63%0.30
6.07%0.29
5.37%0.25
19.43%0.29
24.39%0.30
-4.55%0.27
14.03%0.24
10.15%0.24
-1.92%0.24
28.23%0.29
0.37%0.21
3.41%0.22
-11.64%0.24
14.83%0.22
12.58%0.21
22.22%0.21
64.51%0.28
32.32%0.20
--0.18
--0.17
--0.17
--0.15
Diluted earnings per share
-18.72%0.74
85.68%1.71
3.86%0.94
-21.83%0.70
39.71%0.91
11.24%0.92
27.98%0.91
23.33%0.90
2.76%0.65
30.77%0.83
75.17%0.71
69.93%0.73
50.41%0.63
34.82%0.63
12.06%0.40
2.86%0.43
-1.49%0.42
6.20%0.47
12.43%0.36
20.87%0.42
26.92%0.43
18.48%0.44
17.37%0.32
8.13%0.35
10.69%0.34
12.39%0.37
1.38%0.27
9.85%0.32
-11.04%0.30
-8.56%0.33
1.68%0.27
-6.78%0.29
15.06%0.34
24.74%0.36
5.90%0.27
7.61%0.31
-0.61%0.30
6.13%0.29
5.45%0.25
19.49%0.29
24.46%0.30
-4.49%0.27
14.13%0.24
10.26%0.24
-1.84%0.24
28.38%0.29
0.46%0.21
3.68%0.22
11.70%0.24
15.03%0.22
13.02%0.21
22.23%0.21
30.50%0.22
32.46%0.19
--0.18
--0.17
--0.17
--0.15
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--0.63
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Novo Nordisk A/S's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing NVO stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Novo Nordisk A/S's revenue at year end?

Novo Nordisk A/S reported 46.70B in revenue for fiscal year 2025, up from 42.12B in the previous year.

How much revenue did Novo Nordisk A/S report in the most recent quarter?

Novo Nordisk A/S reported 12.21B in revenue for the most recent quarter, an increase of 4.55% year over year.

What was Novo Nordisk A/S's net income for the year?

Novo Nordisk A/S posted 15.48B in net income for fiscal year 2025.

How much net income did Novo Nordisk A/S post in the last quarter?

Novo Nordisk A/S reported 3.26B in net income for the latest quarter。

What was Novo Nordisk A/S's annual operating profit?

Novo Nordisk A/S's operating income was 21.61B for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.